SCOTT ACOSTA: Open Payments
NPI 1023018199 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 19 payments from 8 companies in 2025. Trend: 2023 $310 · 2024 $361 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $108 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| ABBVIE INC. | 3 | $61 |
| Boston Scientific Corporation | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Cipher Pharmaceuticals US LLC | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: PREVNAR 20, SHINGRIX, UBRELVY, TRELEGY ELLIPTA, PIFELTRO, Dexcom G6 Transmitter, TheraSphere Y90 Glass Microspheres 10 GBq, LINZESS.
Industry payments across LA — which companies pay providers there.
